Brief: Aroa Biosurgery Posts FY Product Revenue NZD 84 Million
28/05/2025 23:44
May 29 (Reuters) - Aroa Biosurgery Ltd ARX.AX: FY PRODUCT REVENUE NZD 84 MILLION FY ADJUSTED EBITDA NZD 4.2 MILLION FY PRODUCT GROSS MARGIN 86% FY ADJUSTED EBIT NZD -800 THOUSAND FY GROSS PROFIT NZD 72.6 MILLION FY ADJUSTED OPERATING EXPENSES NZD 74.5 MILLION TOTAL REVENUE GUIDANCE OF NZ$92-100 MILLION FOR FY26 SEES FY NORMALISED EBITDA OF NZ$5-8 MILLION Further company coverage: ARX.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aroa Biosurgery
See all newsAustralia-listed Aroa Biosurgery climbs as annual earnings beat guidance
Brief: Aroa Biosurgery Posts Adjusted EBITDA Of NZ$12.6 Million
Aroa Biosurgery climbs as prelim annual results beat outlook
Brief: Aroa Biosurgery Posts FY26 Prelim Total Revenue Of NZ$104 Million
Brief: Aroa Biosurgery Says Expects FY26 Revenue At Upper End Of NZ$92-100 Million